(firstQuint)Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer.

 The result of treatment in relapsed and refractory gastric cancer is still not satisfactory.

 For the moment, the combination of 5-Fu and cisplatin is regularly used.

 Capecitabine and Oxaliplatin are new generation drugs of 5-Fu and cisplatin.

 The current study is to evaluate the efficacy and toxicity of this combination.

.

 Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer@highlight

The purpose of this study is to evaluate the efficacy and overall survival of the regimen of XELOX (Xeloda and oxaliplatin combination) in the patients with relapsed and refractory gastric cancer.

